Teladoc Health grants 50,000 RSUs to new Head of Product
Teladoc Health granted 50,000 restricted stock units to David Packles, the new Head of Product of BetterHelp, effective July 1, 2026. The award vests over three years, with one-third vesting on the first anniversary and the remainder quarterly thereafter. Approved by the Compensation Committee, the grant falls under the 2023 Employment Inducement Incentive Award Plan and NYSE Rule 303A.08.
*this image is generated using AI for illustrative purposes only.
Teladoc Health, Inc. granted an inducement award of 50,000 restricted stock units to David Packles, the newly appointed Head of Product of BetterHelp. The award, covering shares of common stock with a par value of $0.001 per share, was effective July 1, 2026. This grant aims to incentivize the new executive as he commences his role within the organization.
The restricted stock units will vest based on Packles' continued service to Teladoc Health. Specifically, one-third of the underlying shares will vest on the first anniversary of the grant date. The remaining shares will vest quarterly over the subsequent two years, ensuring a long-term commitment to the company.
The Compensation Committee of the Board of Directors of Teladoc Health approved the award. It was granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as an employment inducement material to Packles entering into employment with the company. This action was taken pursuant to New York Stock Exchange Rule 303A.08.
Teladoc Health operates as a global leader in virtual care, delivering and orchestrating care across patients, care providers, platforms, and partners. The company focuses on transforming virtual care to improve access, outcomes, provider capacity, and cost efficiency through its relationships with health plans, employers, providers, health systems, and consumers.
Award Details
| Detail | Description |
|---|---|
| Recipient | David Packles, Head of Product of BetterHelp |
| Grant Date | July 1, 2026 |
| Total Shares | 50,000 restricted stock units |
| Par Value | $0.001 per share |
| Vesting Schedule | 33.33% on first anniversary; remainder quarterly over two years |
| Governing Plan | Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan |
| Regulatory Rule | NYSE Rule 303A.08 |
How will David Packles' leadership influence BetterHelp's product roadmap and competitive positioning in the mental health market?
What strategic shifts can we expect in Teladoc's virtual care offerings under the guidance of the new Head of Product?
Could this inducement award signal a broader trend of Teladoc Health attracting top talent to revitalize its growth strategy?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
